CENEGERMIN (Oxervate®)

Clinical Indication

Neurotrophic keratitis

Comments

Not recommended in NICE TA 532

Date of classification

August 2018

Do not prescribe

Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety